双环科技(000707) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was ¥613,202,524.94, a decrease of 26.31% compared to ¥832,130,461.53 in the same period last year[5] - The net profit attributable to shareholders was a loss of ¥9,945,846.80, representing a decline of 106.01% from a profit of ¥165,441,946.23 in the previous year[5] - Operating profit for the current period is -¥12,539,836.99, a drop from ¥165,691,005.16 in the previous period[22] - Basic and diluted earnings per share for the current period are -¥0.0194, compared to ¥0.3564 in the previous period[23] Cash Flow - The net cash flow from operating activities decreased by 82.10% to ¥19,384,538.42, down from ¥108,311,392.08 in the same period last year[5] - Cash flow from operating activities is ¥19,384,538.42, down 82.1% from ¥108,311,392.08 in the previous period[25] - Cash flow from investing activities shows a net outflow of -¥168,090,438.35, compared to a net inflow of ¥105,557,238.37 in the previous period[25] - Cash flow from financing activities has a net inflow of ¥137,494,230.08, contrasting with a net outflow of -¥22,100,433.21 in the previous period[25] - The company's cash and cash equivalents stand at 1,099,846,142.85 RMB, slightly down from 1,111,057,812.70 RMB[17] - The ending cash and cash equivalents balance is ¥1,099,846,142.85, slightly down from ¥995,491,656.92 in the previous period[25] Assets and Liabilities - The total assets at the end of the reporting period were ¥3,952,514,038.28, an increase of 5.98% from ¥3,729,326,962.56 at the end of the previous year[5] - Total liabilities are reported at 1,623,208,620.14 RMB, up from 1,389,484,220.86 RMB[19] - The company's total liabilities increased, with accounts payable rising by 33.33% to ¥379,204,173.95 from ¥284,412,533.83[9] - The total equity attributable to the parent company is 2,329,305,418.14 RMB, a decrease from 2,339,842,741.70 RMB[19] Research and Development - Research and development expenses increased by 84.42% to ¥22,965,755.48, compared to ¥12,453,171.45 in the previous year[10] - Research and development expenses increased to ¥22,965,755.48, up 84.5% from ¥12,453,171.45 in the previous period[22] Shareholder Information - The total number of common shareholders at the end of the reporting period is 43,956[12] - The largest shareholder, Hubei Shuanghuan Chemical Group Co., Ltd., holds 25.11% of the shares, totaling 116,563,210 shares[12] Investment and Other Income - The company reported a significant increase in investment income, which rose by 94.39% to ¥8,985,779.13 from ¥4,622,634.10 in the previous year[10] - The company reported a significant increase in other income, which surged by 3517.58% to ¥2,659,192.37 from ¥73,507.42 in the previous year[11] Share Issuance - The company is currently in the process of issuing shares to raise no more than 708.96 million RMB for acquiring 68.59% equity in Hongyi Chemical Technology Co., Ltd.[14] - The company is awaiting approval from the Shenzhen Stock Exchange for the share issuance, which is currently under review[15]